Acalabrutinib +/- Obinutuzumab vs Obinutuzumab plus Chlorambucil in Treatment-Naive Chronic Lymphocytic Leukemia: 5-Year Follow-Up of ELEVATE-TN
Uwe Martens,Jeff Sharman,Miklos Egyed,Wojciech Jurczak,Alan P. Skarbnik,Manali Kamdar,Talha Munir,Laura Maria Fogliatto,Yair Herishanu,Versha Banerji,George Follows,Patricia Walker,Karin Karlsson,Paolo Ghia,Ann Janssens,Emmanuelle Ferrant,Veerendra Munugalavadla,Ting Yu, Min Hui Wang,Jennifer Woyach HemaSphere（2022）
关键词
leukemia,treatment-naive
AI 理解论文
溯源树
样例
